Literature DB >> 12019309

Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage.

Yuan Zhu1, Guo-Yuan Yang, Barbara Ahlemeyer, Li Pang, Xiao-Ming Che, Carsten Culmsee, Susanne Klumpp, Josef Krieglstein.   

Abstract

Despite the characterization of neuroprotection by transforming growth factor-beta1 (TGF-beta1), the signaling pathway mediating its protective effect is unclear. Bad is a proapoptotic member of the Bcl-2 family and is inactivated on phosphorylation via mitogen-activated protein kinase (MAPK). This study attempted to address whether MAPK signaling and Bad phosphorylation were influenced by TGF-beta1 and, furthermore, whether these two events were involved in the antiapoptotic effect of TGF-beta1. We found a gradual activation of extracellular signal-regulated kinase 1/2 (Erk1/2) and MAPK-activated protein kinase-1 (also called Rsk1) and a concomitant increase in Bad phosphorylation at Ser(112) in mouse brains after adenovirus-mediated TGF-beta1 transduction under nonischemic and ischemic conditions induced by transient middle cerebral artery occlusion. Consistent with these effects, the ischemia-induced increase in Bad protein level and caspase-3 activation were suppressed in TGF-beta1-transduced brain. Consequently, DNA fragmentation, ischemic lesions, and neurological deficiency were significantly reduced. In cultured rat hippocampal cells, TGF-beta1 inhibited the increase in Bad expression caused by staurosporine. TGF-beta1 concentration- and time-dependently activated Erk1/2 and Rsk1 accompanied by an increase in Bad phosphorylation. These effects were blocked by U0126, a mitogen-activated protein kinase/Erk kinase 1/2 inhibitor, suggesting an association between Bad phosphorylation and MAPK activation. Notably, U0126 and a Rsk1 inhibitor (Ro318220) abolished the neuroprotective activity of TGF-beta1 in staurosporine-induced apoptosis, indicating that activation of MAPK is necessary for the antiapoptotic effect of TGF-beta1 in cultured hippocampal cells. Together, we demonstrate that TGF-beta1 suppresses Bad expression under lesion conditions, increases Bad phosphorylation, and activates the MAPK/Erk pathway, which may contribute to its neuroprotective activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12019309      PMCID: PMC6757635          DOI: 20026373

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  52 in total

1.  Reduction of endogenous transforming growth factors beta prevents ontogenetic neuron death.

Authors:  K Krieglstein; S Richter; L Farkas; N Schuster; N Dünker; R W Oppenheim; K Unsicker
Journal:  Nat Neurosci       Date:  2000-11       Impact factor: 24.884

2.  Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway.

Authors:  X Fang; S Yu; A Eder; M Mao; R C Bast; D Boyd; G B Mills
Journal:  Oncogene       Date:  1999-11-18       Impact factor: 9.867

3.  Brain-derived neurotrophic factor-mediated neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on phosphatidyl-inositol-3'-kinase/protein kinase B signaling.

Authors:  N Klöcker; P Kermer; J H Weishaupt; M Labes; R Ankerhold; M Bähr
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

4.  Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia.

Authors:  J Chen; T Nagayama; K Jin; R A Stetler; R L Zhu; S H Graham; R P Simon
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

5.  Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

Authors:  J Zha; H Harada; E Yang; J Jockel; S J Korsmeyer
Journal:  Cell       Date:  1996-11-15       Impact factor: 41.582

6.  Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning.

Authors:  M Gonzalez-Zulueta; A B Feldman; L J Klesse; R G Kalb; J F Dillman; L F Parada; T M Dawson; V L Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

7.  TGF-beta 1 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential neuroprotective mechanisms.

Authors:  P Henrich-Noack; J H Prehn; J Krieglstein
Journal:  Stroke       Date:  1996-09       Impact factor: 7.914

Review 8.  How cells read TGF-beta signals.

Authors:  J Massagué
Journal:  Nat Rev Mol Cell Biol       Date:  2000-12       Impact factor: 94.444

9.  Rsk1 mediates a MEK-MAP kinase cell survival signal.

Authors:  A Shimamura; B A Ballif; S A Richards; J Blenis
Journal:  Curr Biol       Date:  2000-02-10       Impact factor: 10.834

10.  A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside.

Authors:  C N Anderson; A M Tolkovsky
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

View more
  85 in total

Review 1.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

Review 2.  Blood-brain barrier dysfunction, TGFβ signaling, and astrocyte dysfunction in epilepsy.

Authors:  Uwe Heinemann; Daniela Kaufer; Alon Friedman
Journal:  Glia       Date:  2012-02-29       Impact factor: 7.452

3.  Integrin β8 signaling in neonatal hypoxic-ischemic brain injury.

Authors:  Li Zhang; Yi Qu; Binzhi Tang; Fengyan Zhao; Tao Xiong; Donna Ferriero; Dezhi Mu
Journal:  Neurotox Res       Date:  2012-01-25       Impact factor: 3.911

4.  Pro- and anti-inflammatory cytokines regulate the ERK pathway: implication of the timing for the activation of microglial cells.

Authors:  K Saud; R Herrera-Molina; R Von Bernhardi
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

5.  TGFβ signaling induces expression of Gadd45b in retinal ganglion cells.

Authors:  Bin Liu; Xiaoguang Sun; Genn Suyeoka; Joe G N Garcia; Yannek I Leiderman
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-05       Impact factor: 4.799

Review 6.  Transforming growth factor-beta and ischemic brain injury.

Authors:  Alain Buisson; Sylvain Lesne; Fabian Docagne; Carine Ali; Olivier Nicole; Eric T MacKenzie; Denis Vivien
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

7.  Studies on neuronal apoptosis in primary forebrain cultures: neuroprotective/anti-apoptotic action of NR2B NMDA antagonists.

Authors:  Jitendra R Dave; Anthony J Williams; John R Moffett; Michael L Koenig; Frank C Tortella
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

8.  Nicotinamide prevents the long-term effects of perinatal asphyxia on apoptosis, non-spatial working memory and anxiety in rats.

Authors:  Paola Morales; Nicola Simola; Diego Bustamante; Francisco Lisboa; Jenny Fiedler; Peter J Gebicke-Haerter; Micaela Morelli; R Andrew Tasker; Mario Herrera-Marschitz
Journal:  Exp Brain Res       Date:  2009-12-11       Impact factor: 1.972

9.  The role of integrin alpha(v)beta (8) in neonatal hypoxic-ischemic brain injury.

Authors:  Jinhui Li; Yi Qu; Xihong Li; Deyuan Li; Fengyan Zhao; Meng Mao; Donna Ferriero; Dezhi Mu
Journal:  Neurotox Res       Date:  2009-09-23       Impact factor: 3.911

10.  Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia.

Authors:  Li Qian; Sung-Jen Wei; Dan Zhang; Xiaoming Hu; Zongli Xu; Belinda Wilson; Jamel El-Benna; Jau-Shyong Hong; Patrick M Flood
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.